Treatment for Acute Myelogenous Leukemia by Low-Dose, Total-Body, Irradiation-Based Conditioning and Hematopoietic Cell Transplantation From Related and Unrelated Donors
Ute Hegenbart(Heidelberg University), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Hildegard Greinix(Medical University of Graz), Ed Agura, Catherine Cordonnier(Université Paris-Est Créteil), Benedetto Bruno(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Dietger Niederwieser(Leipzig University of Applied Sciences), Thomas R. Chauncey(City Of Hope National Medical Center), Haifa Kathrin Al‐Ali(University Hospital in Halle), Thoralf Lange, Barry E. Storer(City Of Hope National Medical Center), Aloïs Gratwohl, Richard T. Maziarz(Oregon Health & Science University), Brenda M. Sandmaier(University of Washington), Peter A. McSweeney(Mesoblast (United States)), Finn Bo Petersen(Intermountain Healthcare), Bernard Rio(Hotel Dieu Hospital), Judith A. Shizuru(Stanford University), Michael B. Maris(Colorado Blood Cancer Institute), David G. Maloney(Fred Hutch Cancer Center)
Cited by 251
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k